Dose de-escalation to adalimumab 40 mg every 3 weeks in patients with Crohn's disease - a nested case-control study.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: M Ferrante |
| Publication date | February 6, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |